MSL, Hematology

Job description

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. Working With UsChallenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. Role SummaryThe Medical Science Liaison (MSL) advances the BMS medical mission by building trusted, peer-to-peer scientific partnerships and delivering timely data and actionable insights that support appropriate use of BMS medicines and improve patient care. This is a field-based role. The MSL is expected to spend approximately 70–90% of their time with external stakeholders (e.g., thought leaders and HCPs), while maintaining strong therapeutic-area expertise and supporting internal stakeholders. Field time may vary based on asset life cycle, therapeutic area, and geographic scope. Travel is required, primarily domestic. The MSL, Hematology & Pipeline, engages thought leaders (TLs) and HCPs across the Korean hematology community, serving as the therapeutic resource for external and internal stakeholders. The role carries a strong focus on medical launch readiness — shaping the pre-launch scientific environment, building disease-state and treatment-landscape understanding, identifying medical unmet needs, and preparing the medical community for the appropriate introduction of BMS pipeline assets. The MSL develops and executes a territory plan that supports medical education and disease-landscape shaping across hematologic malignancies (e.g., multiple myeloma, lymphoma, leukemia, MDS, MPN) and novel modalities including cellular and immune-based therapies, aligned with the local Hematology Medical Affairs strategy and launch sequence. This role reports on a solid line to the Country Medical Head and on a dotted line to the Hematology Medical Lead. All activities are performed in an ethical and compliant manner, in full adherence with all applicable BMS policies, local laws (including MFDS regulations and the KRPIA Fair Competition Code), and external regulations. Key Responsibilities1. External Engagement and Customer FocusDevelop, maintain, and deepen trusted peer-to-peer relationships with National and Regional Thought Leaders (NTLs/RTLs), HCPs, patient advocacy groups (PAGs), medical societies, and payer stakeholders within a defined geographic scope. Engage with TLs/HCPs through multiple channels (e.g., 1:1 meetings, group presentations, virtual/remote interactions). Continuously profile and assess the medical landscape within hematology, maintaining up-to-date knowledge of treatment strategies, clinical trial activities, unmet medical needs, competitive landscape, and scientific developments. Effectively present scientific and clinical information to HCPs, ensuring medical accuracy and full compliance with local procedures, ethical guidelines, and legal and regulatory directives. Identify and engage potential speakers for BMS educational programmes, ensuring all speakers receive appropriate product and disease-state training. Engage strategically with payers during pre- and peri-launch phases in collaboration with Field HEOR and Market Access where applicable. Leverage digital tools and capabilities — including AI — to enhance the quality, reach, and efficiency of medical engagement. 2. Medical Launch ReadinessShape the pre-launch scientific environment by building disease-state awareness, treatment-landscape understanding, and readiness for the appropriate introduction of BMS pipeline assets among TLs and HCPs. Identify country- and/or ethnic-specific medical unmet needs relevant to launching BMS medicines, and translate them into strategic medical insights that inform launch planning. Develop and execute launch field medical tactics and TL interaction plans aligned with regulatory, access, and medical strategies, and the local launch sequence. Lead/support advisory boards, expert exchange meetings, satellite symposia, and scientific education programmes that build launch-phase scientific readiness. Map and prepare the TL/HCP ecosystem (e.g., treatment centers, key decision-makers, scientific influencers) to support timely and appropriate patient access at launch. Contribute to the medical/scientific sections of pricing and reimbursement files (HIRA/NHIS) where applicable. 3. Medical Planning and ExecutionContribute to the Local/Regional Medical Plan (e.g., launch readiness, medical education priorities, and medical-insight priorities). Develop and execute a scientific engagement plan aligned with hematology therapeutic-area objectives, launch milestones, and stakeholder needs. Use an institution/account planning approach and contribute to cross-functional institution and account plans. Contribute to medical strategy by sharing medical insights and disease-area knowledge, grounded in patient needs and treatment trends. 4. Medical Insights Capture and CommunicationSystematically collect and communicate meaningful medical insights from the field back to internal stakeholders to inform strategy development, medical plans, and pipeline decisions. Gather and share intelligence on the competitive landscape and clinical practice trends to support strategic decision-making. Appropriately document all activities and achieve annual goals in accordance with BMS performance and reporting requirements. Collaborate with other field teams to ensure aligned, consistent, and compliant scientific communications with customers. 5. Clinical Trial and Evidence-Generation SupportSupport Interventional and Non-Interventional Research (NIR) studies by identifying and assessing potential study sites, facilitating patient recruitment, and supporting discussions around the safe and effective use of BMS investigational products — in accordance with local medical management direction and the relevant study scope document. Serve as a point of contact for Investigator-Sponsored Research (ISR) and Pre-Approval Access (PAA)/Managed Access Protocol (MAP) proposals, in compliance with company and legal guidelines. Provide feasibility insights to the clinical development team based on field knowledge, as agreed with local medical management. Ensure that BMS Pharmacovigilance procedural documents are understood and applied by all investigators in local studies; promptly alert appropriate BMS personnel to any identified Adverse Events (AEs). 6. Internal Medical SupportProvide scientific